Compounds > 4-aminophenylethyl-1,4,7,10-tetraazacyclodecane-n,n',n'',n'''-tetraacetic acid
Page last updated: 2024-09-03

4-aminophenylethyl-1,4,7,10-tetraazacyclodecane-n,n',n'',n'''-tetraacetic acid and Colonic Neoplasms

4-aminophenylethyl-1,4,7,10-tetraazacyclodecane-n,n',n'',n'''-tetraacetic acid has been researched along with Colonic Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buchsbaum, DJ; Roberson, PL; Rogers, BE; Yokoyama, S1
Cheng, R; Colcher, D; Eggensperger, D; Fordyce, W; Goeckeler, W; Kruper, WJ; Milenic, DE; Schlom, J; Schott, ME; Siler, K1
Brechbiel, MW; Chappell, LL; Dadachova, E; Garmestani, K; Ma, D; Milenic, DE; Schlom, J; Yordanov, A1

Other Studies

3 other study(ies) available for 4-aminophenylethyl-1,4,7,10-tetraazacyclodecane-n,n',n'',n'''-tetraacetic acid and Colonic Neoplasms

ArticleYear
Three-dimensional dose model for the comparison of 177Lu-HuCC49DeltaCH2 and 177Lu-HuCC49 radioimunotherapy in mice bearing intraperitoneal xenografts.
    Cancer biotherapy & radiopharmaceuticals, 2003, Volume: 18, Issue:2

    Topics: Aniline Compounds; Animals; Antibodies, Monoclonal; Colonic Neoplasms; Dose-Response Relationship, Radiation; Heterocyclic Compounds; Humans; Lutetium; Mice; Mice, Nude; Models, Biological; Neoplasms, Experimental; Peritoneal Neoplasms; Radioimmunotherapy; Radiotherapy Dosage; Tissue Distribution; Transplantation, Heterologous

2003
Biodistribution and preclinical radioimmunotherapy studies using radiolanthanide-labeled immunoconjugates.
    Cancer, 1994, Feb-01, Volume: 73, Issue:3 Suppl

    Topics: Aniline Compounds; Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Colonic Neoplasms; Glycoproteins; Heterocyclic Compounds; Humans; Immunotoxins; Iodine Radioisotopes; Lutetium; Metals, Rare Earth; Mice; Mice, Nude; Neoplasm Transplantation; Radioimmunotherapy; Radioisotopes; Samarium; Tissue Distribution; Transplantation, Heterologous; Yttrium Radioisotopes

1994
In vivo comparison of macrocyclic and acyclic ligands for radiolabeling of monoclonal antibodies with 177Lu for radioimmunotherapeutic applications.
    Nuclear medicine and biology, 2002, Volume: 29, Issue:4

    Topics: Adenocarcinoma; Aniline Compounds; Animals; Antibodies, Monoclonal; Colonic Neoplasms; Female; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Immunoconjugates; Isothiocyanates; Lutetium; Mice; Mice, Nude; Pentetic Acid; Radioimmunotherapy; Radiopharmaceuticals; Sensitivity and Specificity; Tissue Distribution; Whole-Body Counting; Xenograft Model Antitumor Assays

2002